In vitro stability of a novel compliant poly(carbonate-urea) urethane to oxidative and hydrolytic stress

被引:1
|
作者
Salacinski, HJ
Tai, NR
Carson, RJ
Edwards, A
Hamilton, G
Seifalian, AM
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Dept Surg, Tissue Engn Labs, London NW3 2QG, England
[2] Cardiotech Int Ltd, Wrexham, Wales
来源
关键词
vascular grafts; compliant poly(carbonateurea)urethane; viscoelasticity; hydrolytic; oxidative; peroxidative and plasma-fraction-led degradation;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Poly(ester) urethane and poly(ether)urethane vascular grafts fail in vivo because of hydrolytic and oxidative degradative mechanisms. Studies have shown that poly(carbonate)urethanes have enhanced resistance. There is still a need for a viable, nonrigid, small-diameter, synthetic vascular graft. In this study, we sought to confirm this by exposing a novel formulation of compliant poly(carbonate)urethane (CPU) manufactured by an innovative process, resulting in a stress-free. Small-diameter prosthesis, and a conventional poly(ether) urethane Pulse-Tec graft known to readily undergo oxidation in a variety of degradative solutions, and we assessed them for the development of oxidative and hydrolytic degradation, changes in elastic properties, and chemical stability. To simulate the in vivo environment, we used buffered solutions of phospholipase A(2) and cholesterol esterase; solutions of H2O2/CoCl2, t-butyl peroxide/CoCl2 (t-but/CoCl2), and glutathione/t-butyl peroxide/CoCl2 (Glut/t-but/CoCl2); and plasma fractions I-IV, which were derived from fresh human plasma centrifuged in poly(ethylene glycol). To act as a negative control, both graft types were incubated in distilled water. Samples of both graft types (100 mm with a 5.0-mm inner diameter) were incubated in these solutions at 37 degreesC for 70 days before environmental scanning electron microscopy, radial tensile strength and quality control, gel permeation chromatography, and in vitro compliance assessments were performed. Oxidative degradation was ascertained from significant changes in molecular weight with respect to a control on all Pulse-Tec grafts treated with t-but/CoCl2, Glut/ t-but/CoCl2, and plasma fractions I-III. Pulse-Tec grafts exposed to the H2O2/CoCl2 mixture had significantly greater compliance than controls incubated in distilled water (p < 0.001 at 50 mmHg). No changes in molecular weight with respect to the control were observed for the CPU samples; only those immersed in t-but/CoCl2 and Glut/t-but,/CoCl2 showed an 11% increase in molecular weight to 108,000. Only CPU grafts treated with the Glut/t-but/CoCl2 mixture exhibited significantly greater compliance (p < 0.05 at 50 mmHg). Overall, results from this study indicate that CPU presents a far greater chemical stability than poly(ether)urethane grafts do. 2001 John Wiley & Sons, Inc.
引用
收藏
页码:207 / 218
页数:12
相关论文
共 50 条
  • [1] Thermo-mechanical analysis of a compliant poly(carbonate-urea)urethane after exposure to hydrolytic, oxidative, peroxidative and biological solutions
    Salacinski, HJ
    Odlyha, M
    Hamilton, G
    Seifalian, AM
    BIOMATERIALS, 2002, 23 (10) : 2231 - 2240
  • [2] Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress
    Salacinski, HJ
    Tai, NR
    Punshon, G
    Giudiceandrea, A
    Hamilton, G
    Seifalian, AM
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (04) : 342 - 352
  • [3] In vivo biostability of a poly(carbonate-urea)urethane graft
    Seifalian, AM
    Salacinski, HJ
    Tiwari, A
    Edwards, A
    Bowald, S
    Hamilton, G
    BIOMATERIALS, 2003, 24 (14) : 2549 - 2557
  • [4] A comprehensive bio-material investigation of the chemical and thermal stability of a new poly(carbonate-urea)urethane "MyoLink®" used in the manufacture of cardiovascular grafts to oxidative and hydrolytic stress
    Salacinski, HJ
    Tai, NR
    Carson, RJ
    Edwards, A
    Hamilton, G
    Seifalian, AM
    FASEB JOURNAL, 2001, 15 (04): : A85 - A85
  • [5] Tissue-engineering of a novel poly(carbonate-urea) urethane vascular graft MyoLink®
    Krijgsman, B
    Salacinski, HJ
    Punshon, G
    Seifalian, AM
    Hamilton, G
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 16 - 16
  • [6] Tissue-engineering of a novel poly(carbonate-urea)urethane vascular graft "MyoLinK®"
    Punshon, G
    Seifalian, AM
    Salacinski, HJ
    Krigsman, B
    Hamilton, G
    FASEB JOURNAL, 2001, 15 (05): : A1129 - A1129
  • [7] Engineering a bioartificial liver: optimisation of hepatocyte seeding in poly(carbonate-urea) urethane conduits
    Punshon, G
    Salacinski, H
    Seifalian, AM
    Davidson, BR
    FASEB JOURNAL, 2003, 17 (04): : A270 - A271
  • [8] Usage of microscopic thermo-mechanical analysis to assess the in vitro stability of a new compliant poly(earbonate-silsequioxane-urea)urethane exposed to oxidative, hydrolytic, and peroxidative stresses
    Salacinski, HJ
    de Groot, J
    Odlyha, M
    Hamilton, G
    Seifalian, AM
    MATRIX BIOLOGY, 2004, 23 (06) : 411 - 412
  • [9] Hybrid bypass graft made from compliant poly(carbonate-urea)urethane scaffold, human smooth muscle and endothelial cells from the same patient
    Rashid, ST
    Salacinski, HJ
    Button, MJC
    Tohill, M
    Fuller, B
    Seifalian, AA
    Hamilton, G
    BRITISH JOURNAL OF SURGERY, 2005, 92 (10) : 1323 - 1323
  • [10] Hydrolytic stability of aliphatic poly(carbonate-urea-urethane)s: Influence of hydrocarbon chain length in soft segment
    Mazurek-Budzynska, Magdalena
    Behl, Marc
    Razzaq, Muhammad Y.
    Noechel, Ulrich
    Rokicki, Gabriel
    Lendlein, Andreas
    POLYMER DEGRADATION AND STABILITY, 2019, 161 : 283 - 297